Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2251 - 2275 of 2778 in total
Name Weight StructureDescriptionCategories
Sultamicillin594.65

C25H30N4O9S2
A mutual prodrug of ampicillin and sulbactam useful in the treatment of infections caused by beta-lactamase-producing bacteria.Anti-Bacterial Agents
Lorlatinib406.421

C21H19FN6O2
An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors
Gilteritinib552.724

C29H44N8O3
An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.Protein Kinase Inhibitors
Erdafitinib446.555

C25H30N6O2
A fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
Brincidofovir561.701

C27H52N3O7P
An oral lipid prodrug of cidofovir used in the treatment of human smallpox disease.Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
Citicoline488.324

C14H26N4O11P2
An endogenous intermediate in the formation of phosphatidylcholine from choline which is thought to have neuroprotective effects.Cytidine Diphosphate / Nootropic Agents
Deutetrabenazine323.466

C19H27NO3
A vesicular monoamine transporter 2 inhibitor used for the symptomatic treatment of tardive dyskinesia and chorea associated with Huntington's disease.Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Heterocyclic Compounds, Fused-Ring / Highest Risk QTc-Prolonging Agents / Nervous System / QTc Prolonging Agents / Quinolizines / Vesicular Monoamine Transporter 2 Inhibitor / Vesicular Monoamine Transporter 2 Inhibitors
Gepirone359.474

C19H29N5O2
A serotonin receptor agonist used to treat major depressive disorder in adultsAnti-Anxiety Agents / Serotonin Receptor Agonists
Iron isomaltoside 1000Not AnnotatedIron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney...Hematinics
Capivasertib428.915

C21H25ClN6O2
A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerProto-Oncogene Proteins c-akt, antagonists & inhibitors
Estetrol304.3808

C18H24O4
An estrogen used in combination with drospirenone for oral contraception.Estrogens
Bexagliflozin464.94

C24H29ClO7
A sodium-glucose co-transporter 2 inhibitor used to improve glycemic control in patients with type 2 diabetes mellitus.Blood Glucose Lowering Agents
Edaravone174.203

C10H10N2O
A free radical scavenger used to delay the progression of ALS.Free Radical Scavengers / Neuroprotective Agents
Triclabendazole359.65

C14H9Cl3N2OS
An anthelmintic drug used to treat fascioliasis.Antihelminthic / Antiplatyhelmintic Agents / Benzimidazoles
Vadadustat306.7

C14H11ClN2O4
An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis.Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (weak) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Erythropoiesis-Stimulating Agents / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT3/SLC22A8 Inhibitors / OAT3/SLC22A8 Substrates / Pyridines / UGT1A1 Inducers / UGT1A1 Substrates / UGT1A9 Substrates / UGT2B7 substrates
Fexinidazole279.31

C12H13N3O3S
An orally bioavailable 2-substituted 5-nitroimidazole used to treat early- and late-stage human African trypanosomiasis caused by Trypanosoma brucei gambiense.Nitroimidazole Derivatives
Brigatinib584.1

C29H39ClN7O2P
An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer.Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors
PolihexanideNot AnnotatedPolihexanide has been used in trials studying the treatment, prevention, and supportive care of Caries, Neoplasm, Skin Diseases, Nail Diseases, and Dental Plaque, among others.Biguanides and Amidines
Propiverine367.4813

C23H29NO3
An antimuscarinic agent used to treat urinary incontinence or increased urinary frequency or urgency.Drugs for Urinary Frequency and Incontinence
Nefopam253.345

C17H19NO
A non-opioid analgesic used for moderate to severe pain, especially post-surgical pain.Analgesics
P-nitrobiphenyl199.209

C12H9NO2
Pnb has been used in trials studying the treatment of Pelvic Organ Prolapse.Not Annotated
Doravirine425.749

C17H11ClF3N5O3
A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections.Non-Nucleoside Reverse Transcriptase Inhibitors
Dopexamine356.5017

C22H32N2O2
Dopexamine has been used in trials studying the diagnostic and treatment of Free Flap, Oral Cancer, Hypotension, Septic Shock, and Head and Neck Cancer.Adrenergic and Dopaminergic Agents
Cantharidin196.202

C10H12O4
A natured product indicated to treat molluscum contagiosumBenzofurans / Enzyme Inhibitors / Irritants
Eravacycline558.563

C27H31FN4O8
A tetracycline antibiotic used to treat complicated intra-abdominal infections.Tetracyclines
Displaying drugs 2251 - 2275 of 2778 in total